Revision Medialization Thyroplasty for Glottic Insufficiency Amid Rapid Weight Loss on Semaglutide.
Laryngoscope · 2026
Last updated 2026-08-28| Journal | Laryngoscope, 2026 |
|---|---|
| Citations | 0 |
| Molecules | semaglutide |
Abstract
A 74-year-old female presented to clinic 9 years after successful bilateral medialization thyroplasty surgery with new onset voice deterioration. This coincided with a 25-pound weight loss while taking semaglutide. Evaluation revealed marked vocal fold atrophy and glottic insufficiency. She underwent successful revision thyroplasty surgery to accommodate functional voice quality changes concurrent with rapid weight loss on GLP1 agonist.
Verbatim abstract via PubMed 42439301 ↗
Related research
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity.
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
- Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.